Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant521 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 619 | Parabilis Medicines, Inc.INDUSTRY | 2 | Aug 17, 2026 | clinicaltrials |
| NCT06221020 | To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery | recruiting | — | 70 | Chang Gung Memorial HospitalOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT06632236 |
| 5G-EMERALD: Amivantamab in Malignant Brain Tumours(5G-EMERALD) |
| active not recruiting |
| Phase 1 |
| 12 |
| Institute of Cancer Research, United KingdomOTHER |
| 1 |
| Aug 17, 2026 |
| clinicaltrials |
| NCT06894979 | Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma | active not recruiting | Phase 1 | 54 | Children's Oncology GroupNETWORK | 1 | Aug 17, 2026 | clinicaltrials |
| NCT07769099 | Musical Training: Promoting Brain Function in Children Who Have Survived Brain Tumours | not yet recruiting | N/A | 236 | The Hong Kong Polytechnic UniversityOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT03652545 | Multi-antigen T Cell Infusion Against Neuro-oncologic Disease(REMIND) | active not recruiting | Phase 1 | 33 | Catherine BollardOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT01326104 | Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor(Re-MATCH) | completed | Phase 2 | 26 | University of FloridaOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT03389802 | Phase I Study of APX005M in Pediatric Central Nervous System Tumors | completed | Phase 1 | 32 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Aug 13, 2026 | clinicaltrials |
| NCT03871257 | A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma | active not recruiting | Phase 3 | 165 | National Cancer Institute (NCI)NIH | 3 | Aug 13, 2026 | clinicaltrials |
| NCT04940507 | BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial(BRAINFUL) | active not recruiting | N/A | 50 | University Health Network, TorontoOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT05476939 | Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0(BIOMEDE 2) | recruiting | Phase 3 | 433 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 6 | Aug 13, 2026 | clinicaltrials |
| NCT07716579 | Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment | completed | N/A | 12 | Institute of Oncology LjubljanaOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT02300766 | Cerebellar Mutism Syndrome Study | recruiting | — | 2,000 | Rigshospitalet, DenmarkOTHER | 14 | Aug 12, 2026 | clinicaltrials |
| NCT04696029 | DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma | recruiting | Phase 2 | 118 | Giselle ShollerOTHER | 2 | Aug 12, 2026 | clinicaltrials |
| NCT05777499 | MUSic Therapy In Complex Specialist Neurorehabilitation(MUSICS) | completed | N/A | 80 | University College, LondonOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06161519 | PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications | recruiting | Phase 1 / Phase 2 | 146 | National Cancer Institute (NCI)NIH | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06777433 | Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases(RAD101) | active not recruiting | Phase 2 | 30 | Radiopharm Theranostics, LtdINDUSTRY | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07186556 | Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention | recruiting | N/A | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT00950001 | Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases | active not recruiting | Phase 3 | 132 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT03606161 | Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors | active not recruiting | N/A | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT03739372 | Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma(PNOC008) | completed | N/A | 44 | University of California, San FranciscoOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT05057702 | Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma(PNOC027) | recruiting | N/A | 74 | University of California, San FranciscoOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT03542409 | Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas | completed | Early Phase 1 | 53 | University of UtahOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT03741673 | Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases | active not recruiting | Phase 3 | 180 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT04692337 | Ommaya Reservoir Placement for Brain Tumor Biomarker Access | recruiting | N/A | 100 | Mayo ClinicOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07383649 | Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection | recruiting | Phase 2 | 28 | The Methodist Hospital Research InstituteOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT03281889 | Proton Craniospinal Irradiation With Bone Sparing to Decrease Growth Decrement From Radiation | active not recruiting | N/A | 20 | Massachusetts General HospitalOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT06391294 | Neuronal and Network Mechanisms of Electrocortical Stimulation | enrolling by invitation | N/A | 65 | Northwestern UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07558473 | Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors | not yet recruiting | N/A | 300 | Hugo W. Moser Research Institute at Kennedy Krieger, Inc.OTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT01837862 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | active not recruiting | Phase 1 / Phase 2 | 10 | Julie KrystalOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT01891318 | Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study | recruiting | Phase 1 / Phase 2 | 36 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05086497 | WBSI Guided Personalized Delivery of TTFields | recruiting | N/A | 155 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07003542 | A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas | recruiting | Phase 2 | 48 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT03604302 | Evaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain Tumors | active not recruiting | N/A | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT04810871 | Surgical Resection of Latent Brain Tumors Prior to Recurrence | suspended | N/A | 40 | Mayo ClinicOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06322602 | Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors | recruiting | N/A | 30 | Mayo ClinicOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06822842 | Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models | completed | — | 1,229 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT07415668 | Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning(MENTOR) | recruiting | N/A | 30 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT07680439 | Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). | recruiting | Phase 2 | 75 | BrainChild Bio, IncINDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT03726359 | Phase I Study of Fractionated Stereotactic Radiation Therapy | recruiting | N/A | 43 | Albert Einstein College of MedicineOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT04099797 | C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) | recruiting | Phase 1 | 56 | Baylor College of MedicineOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT04320888 | Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial | active not recruiting | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 3 | Aug 3, 2026 | clinicaltrials |
| NCT06239272 | NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) | recruiting | Phase 1 / Phase 2 | 139 | St. Jude Children's Research HospitalOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT06624371 | Atovaquone Combined With Radiation in Children With Malignant Brain Tumors(AflacBT2303) | recruiting | Phase 1 | 18 | Emory UniversityOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07206849 | Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) | not yet recruiting | Phase 2 | 79 | Nationwide Children's HospitalOTHER | 0 | Jul 31, 2026 | clinicaltrials |
| NCT07259304 | Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors | active not recruiting | — | 118 | University of Southern CaliforniaOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT07402343 | Tarlatamab for SCLC Brain Metastases(T-BRAIN) | recruiting | Phase 2 | 35 | Maastricht University Medical CenterOTHER | 1 | Jul 31, 2026 | clinicaltrials |
| NCT03598244 | Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors | active not recruiting | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 2 | Jul 30, 2026 | clinicaltrials |
| NCT04337177 | Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors | active not recruiting | Phase 1 | 20 | Valent Technologies, LLCINDUSTRY | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05047913 | Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR | active not recruiting | Early Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 17, 2026source: clinicaltrials